Peng Sun
1 appearance in the program
Sessions & presentations
PS16: Advancing Rare Disease Drug Development: Leveraging External Controls and Novel Statistical Methods to Drive Regulatory Success
Presenting Author
Presentation: Use of External Controls for the Primary Analysis of a Randomized Phase 3 Study to Evaluate a Higher Dose Regimen of SPINRAZA for the Treatment of Spinal Muscular Atrophy (SMA)
Parallel · Thu, Sep 25 , 2:45 PM